EVFM(Evofem Biosciences, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $8.24M | $16.84M | $18.22M | $19.36M | $20.18M |
| 毛利润 | $4.19M | $12.42M | $11.71M | $15.53M | $15.57M |
| 营业利润 | −$166.80M | −$84.12M | −$17.85M | −$7.68M | $3.37M |
| 净利润 | −$205.19M | −$76.70M | $52.98M | −$8.86M | $391.00K |
| 经营现金流 | −$146.67M | −$70.41M | −$8.97M | −$3.88M | −$1.99M |
| 自由现金流 | −$149.61M | −$70.75M | −$8.97M | −$3.90M | −$2.00M |
| 摊薄每股收益 | — | — | $75.00 | $-165.00 | $0.00 |